What is the optimal approach for tranexamic acid application in patients with unilateral total hip arthroplasty?;Welcher Weg der Tranexamsäureapplikation ist bei Patienten mit einseitiger Hüfttotalendoprothese optimal?

Orthopade

Volumn 45, Issue 7, 2016, Pages 616-621

  Zhang, Ying ^a,b   Zhang, Leilei ^a,b   Ma, Xianghao ^a,b   Jia, Yudong ^a,b   Wang, Huichao ^a,b   Zhu, Yingjie ^a,b   Liu, Youwen ^a,b  

^a Luoyang Orthopedic Traumatological Hospital   (China)

^b Orthopedics Hospital of Henan Province   (China)

Author keywords

Adverse effects; Orthopedics; Osteonecrosis of the femoral head; Randomized controlled study; Safety

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; COMPLICATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HIP REPLACEMENT; HUMAN; MALE; MIDDLE AGED; OSTEONECROSIS; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84965017920     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-016-3252-y     Document Type: Article

References (27)

1. Mednick RE, Alvi HM, Krishnan V et al (2014) Factors affecting readmission rates following primary total hip Arthroplasty. J Bone Joint Surg Am 96(14):1201–1209
2. Gibon E, Courpied JP, Hamadouche M (2013) Total joint replacement and blood loss: what is the best equation. Int Orthop 37:735–739
3. Bierbaum BE, Callaghan JJ, Galante JO et al (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81:2–10
4. Massicotte L, Denault AY, Beaulieu D et al (2011) Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation 91:1273
5. Dhir A (2014) Antifibrinolytics in cardiac surgery. Ann Card Anaesth 16:117–125
6. Roy SP, Tanki UF, Dutta A et al (2012) Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 20:2494–2501
7. Alshryda S, Mason J, Vaqhela M et al (2013) Topical(intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial. J Bone Joint Surg Am 95:1961–1968
8. Maniar RN, Kumar G, Singhi T et al (2014) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patient. Clin Orthop 470:2605–2612
9. Blanie A, Bellamy L, Rhayem Y et al (2013) Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thromb Res 131(1):6–11
10. Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM (2014) A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 96-B:1005–1015
11. Nadler SB, Hidalgo JU, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224
12. Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 86(4):561
13. Tai TW, Chang CW, Lai KA et al (2012) Effects of Tourniquet Use on Blood Loss and Soft-Tissue Damage in Total Knee Arthroplasty:A Randomized Controlled Trial. J Bone Joint Surg 94(24):2209–2215
14. Liu X, Zhang X, Chen Y et al (2011) Hidden blood loss after total hip arthroplasty. J Arthroplasty 26(7):1100–1105
15. Li B, Wen Y, Liu D et al (2012) The effect of knee position on blood loss and range of motion following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 20(3):594–599
16. Markar SR, Jones GG, Karthikesalingam A (2012) Transfusion drains versus suction drains in total knee replacement: meta-analysis. Knee Surg Sports Traumatol Arthrosc 20(9):1766–1772
17. Syrovets T, Lunov O, Simmet T (2012) Plasmin as a proinflammatory cell activator. J Leukoc Biol 92(3):509–519
18. Imai N, Dohmae Y, Suda K et al (2012) Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 27(1843):1838
19. McCormack PL (2012) Tranexamic acid a review of its use in the treatment of hyper fibrinolysis. Drugs 72:585–617
20. Irisson E, Hemon Y, Pauly V et al (2012) Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 98:477–483
21. Clave A, Fazilleau F, Dumser D et al (2012) Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thrombopro- phylaxis: a case-control study in 70 patients. Orthop Traumatol Surg Res 98(5):484–490
22. Alshryda S, Mason J, Sarda P et al (2013) Topical(intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 95:1969–1974
23. Gilbody J, Dhotar HS, Perruccio AV et al (2014) Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 29:681–684
24. Konig G, Hamlin BR, Waters JH (2013) Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplast 28:1473–1476
25. Huotari K, Agthe N, Lyytikainen O (2007) Validation of surgical siteinfection surveillance in orthopedic procedures. Am J Infect Control 35:216–221
26. Yue C, Kang PD, Yang PQ, Xie JW, Pei FX (2014) Topical application of Tranexamic acid in primary total hip Arthroplasty: A randomized double-blind controlled trial. J Arthroplast 29(12):2452–2456
27. Wei W, Wei BE (2014) Comparison of topical and intravenous Tranexamic acid on blood loss and transfusion rates in total hip Arthroplasty. J Arthroplast 29(11):2113–2116